Soichiro Adachi
Yokohama, 2360004, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Human Monocytic Models Reveal Genotype-Dependent Inflammatory Programs in VEXAS Syndrome.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 03, 2026
Performance of Developed Mononuclear Cell Separator for Regenerative Therapy Is Comparable to Manual.
Journal: Tissue engineering. Part C, Methods
Published: October 13, 2025
Successful re-administration of tocilizumab in a patient with adult-onset Still's disease after improvement of macrophage activation syndrome.
Journal: Modern rheumatology case reports
Published: January 04, 2025
Distinct features of trisomy 8-associated autoinflammatory disease from Behçet's disease: case series and systematic review.
Journal: Clinical and experimental rheumatology
Published: August 09, 2024
Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome.
Journal: Rheumatology advances in practice
Published: January 08, 2024
Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still's Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience.
Journal: Rheumatology and therapy
Published: July 18, 2023
Erratum to: A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study.
Journal: BMC research notes
Published: February 08, 2017
A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study.
Journal: BMC research notes
Published: May 17, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026